Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

ClinicalTrials.gov ID: NCT01226563

Public ClinicalTrials.gov record NCT01226563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo Controlled, Multicenter, Randomized Double Blind Trial to Evaluate the Safety and Effectiveness of IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective is to evaluate the safety and effectiveness of the IK-5001 device for the prevention of ventricular remodeling and congestive heart failure when administered to subjects who had successful percutaneous coronary intervention with stent placement after ST segment elevation MI (STEMI).

Study identification

NCT ID
NCT01226563
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Bellerophon BCM LLC
Industry
Enrollment
303 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2012
Primary completion
Jul 31, 2015
Completion
Nov 30, 2015
Last update posted
Feb 26, 2023

2012 – 2015

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
Cardiology, P.C. Birmingham Alabama 35211
Harbor - UCLA Medical Center Torrance California 90509
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010
University of Florida Gainesville Florida 32610
University of Miami Hospital Miami Florida 33136
St. Vincent Medical Group Inc. Indianapolis Indiana 46290
Henry Ford Health System Detroit Michigan 48202
Minneapolis Heart Institute Minneapolis Minnesota 55407
Stony Brook Medicine Stony Brook New York 11794
Montefiore Medical Center Weiler Division The Bronx New York 10461
East Carolina Heart Institute - ECHI Greenville North Carolina 27834
Carl and Edyth Lindner Center for Research and Education @ Christ Hospital Cincinnati Ohio 45219
Ohio Health Research Institute Columbus Ohio 43214
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Rhode Island Hospital Providence Rhode Island 02903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01226563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2023 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01226563 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →